# SEARCH

** Antitarget Pharmacophore Models **

** Application of Pharmacophore Models in Virtual Screening **

** CATALYST pharmacophoric models **

** Chemoinformatics pharmacophore model **

** Cross-Chemotype Pharmacophore Models **

** Descriptors from a Pharmacophore Model **

** Direct approaches, pharmacophore modeling **

** Distance geometry pharmacophore modeling **

** Docking and Pharmacophore Modelling for Virtual Screening **

** Dopamine transporter pharmacophore model **

** Dopamine-transporter inhibitors pharmacophore model **

** Drug design pharmacophore model **

** Epothilone pharmacophore model **

** Food-related components pharmacophore model **

** Grid-based pharmacophore model **

** Grid-based pharmacophore model GBPM) **

** Interpretation pharmacophoric model **

** Ligand-based Pharmacophore Modeling **

** Linear QSAR models descriptor pharmacophores **

** Modeling of Selective Pharmacophores at the arAdrenergic Receptors **

** Molecular modeling pharmacophore-based ligand **

** Molecular modelling receptor/pharmacophore mapping **

** Nicotinic Pharmacophore Models **

** Paclitaxel/epothilone pharmacophore model **

** Pharmacophore Combination Approach From Lock and Key to Passe-Partout Model **

** Pharmacophore Identification and Pseudo-Receptor Modeling **

** Pharmacophore Model Generation **

** Pharmacophore Modelling in SCHRODINGER **

** Pharmacophore Models as Part of a Multi-step Screening Approach **

** Pharmacophore Models for Activity Profiling and Parallel Virtual Screening **

** Pharmacophore Models for Virtual Screening **

** Pharmacophore Models into Receptor Site **

** Pharmacophore mapping molecular modelling **

** Pharmacophore modeling software **

** Pharmacophore pseudo-receptor models **

** Pharmacophores published models **

** Qualitative pharmacophore models **

** Quantitative pharmacophore models **

** Structure-based pharmacophore modeling **

** Supermolecule-Based Subtype Pharmacophore and QSAR Models **